+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Glucosamine Market by Application and Geography - Forecast and Analysis 2020-2024 - Product Image

Glucosamine Market by Application and Geography - Forecast and Analysis 2020-2024

  • ID: 4860960
  • Report
  • 145 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Blackmores Ltd.
  • Cargill Inc.
  • Ethical Naturals Inc.
  • GNC Holdings Inc.
  • Natures Aid Ltd.
  • NOW Health Group Inc.
  • MORE
Global Glucosamine Market: About this market
The glucosamine market analysis considers sales from both arthritis and other applications. Our study also finds the sales of glucosamine in Asia, Europe, North America, and ROW. In 2018, the arthritis segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising transition to nutraceuticals and dietary supplements will play a significant role in the arthritis segment to maintain its market position. Also, our global glucosamine market report looks at factors such as increasing use of combination therapy, growing popularity of e-commerce in healthcare industry, and growing geriatric population. However, limitations on variation of molecule type, wide availability of substitutes, and stringent regulations may hamper the growth of the glucosamine industry over the forecast period.

Global Glucosamine Market: Overview

Increasing the use of combination therapy
Although there are a substantial number of drugs available for the treatment of joint-related conditions, many researchers believe chronic conditions such as osteoarthritis do not respond to a monotherapy drug or a single treatment. Treatments of such conditions are most effective when given in combination. In combination therapy, nutraceutical supplements such as glucosamine are administered along with other drugs or dietary supplements such as chondroitin. Hence, the use of combination therapy will lead to the expansion of the global glucosamine market at a CAGR of over 6% during the forecast period.

Growing use of nutraceuticals in treating chronic diseases
Nutraceuticals such as glucosamine supplements are used to treat and manage various chronic diseases owing to their additional nutritional and therapeutic effects along with their health benefits and lesser side effects compared with drugs. A nutraceutical also offers physiological benefits such as protection against various chronic diseases and lifestyle disorders (obesity and cardiovascular diseases). Apart from effectively treating orthopedic conditions in combination therapy, glucosamine is also used to manage conditions such as interstitial cystitis, multiple sclerosis, and others. Vendors are also focusing on making non-animal-derived glucosamine to cater to individuals who are allergic to crustaceans and follow a kosher diet. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of several major players, the global glucosamine market is highly fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading glucosamine manufacturers, that include Blackmores Ltd., Cargill Inc., Ethical Naturals Inc., GNC Holdings Inc., Herbs Nutriproducts Pvt. Ltd., Jyorana International Pvt. Ltd., Natures Aid Ltd., NOW Health Group Inc., Pharma Nord Aps, and WynnPharm Inc.

Also, the glucosamine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Blackmores Ltd.
  • Cargill Inc.
  • Ethical Naturals Inc.
  • GNC Holdings Inc.
  • Natures Aid Ltd.
  • NOW Health Group Inc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
  • Market segmentation by application
  • Comparison by application
  • Arthritis - Market size and forecast 2019-2024
  • Other applications - Market size and forecast 2019-2024
  • Market opportunity by application
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Growing use of nutraceuticals in treating chronic diseases
  • Shift toward production of glucosamine from vegetarian sources
  • Increasing research funding in the field of nutraceuticals
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Blackmores Ltd.
  • Cargill Inc.
  • Ethical Naturals Inc.
  • GNC Holdings Inc.
  • Herbs Nutriproducts Pvt. Ltd.
  • Jyorana International Pvt. Ltd.
  • Natures Aid Ltd.
  • NOW Health Group Inc.
  • Pharma Nord Aps
  • WynnPharm Inc.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Key offerings
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Application - Market share 2019-2024 (%)
Exhibit 19: Comparison by application
Exhibit 20: Arthritis - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: % Prevalence of arthritis by age in the US in 2013-15
Exhibit 22: Arthritis - Year-over-year growth 2020-2024 (%)
Exhibit 23: Other applications - Market size and forecast 2019-2024 ($ millions)
Exhibit 24: Other applications - Year-over-year growth 2020-2024 (%)
Exhibit 25: Market opportunity by application
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2019-2024 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 30: North America - Year-over-year growth 2020-2024 (%)
Exhibit 31: Top 3 countries in North America
Exhibit 32: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 34: Top 3 countries in Europe
Exhibit 35: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 36: Proportion of geriatric population in Asia 2009 and 2018 (% of the total population)
Exhibit 37: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 40: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Growth of geriatric population 2009-2018 (%)
Exhibit 45: Alternative therapies for treating orthopedic conditions
Exhibit 46: Impact of drivers and challenges
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Blackmores Ltd. - Vendor overview
Exhibit 53: Blackmores Ltd. - Business segments
Exhibit 54: Blackmores Ltd. - Organizational developments
Exhibit 55: Blackmores Ltd. - Segment focus
Exhibit 56: Blackmores Ltd. - Key offerings
Exhibit 57: Cargill Inc. - Vendor overview
Exhibit 58: Cargill Inc. - Business segments
Exhibit 59: Cargill Inc. - Organizational developments
Exhibit 60: Cargill Inc. - Geographic focus
Exhibit 61: Cargill Inc. - Key offerings
Exhibit 62: Ethical Naturals Inc. - Vendor overview
Exhibit 63: Ethical Naturals Inc. - Business segments
Exhibit 64: Ethical Naturals Inc. - Key offerings
Exhibit 65: GNC Holdings Inc. - Vendor overview
Exhibit 66: GNC Holdings Inc. - Business segments
Exhibit 67: GNC Holdings Inc. - Geographic focus
Exhibit 68: GNC Holdings Inc. - Segment focus
Exhibit 69: GNC Holdings Inc. - Key offerings
Exhibit 70: Herbs Nutriproducts Pvt. Ltd. - Vendor overview
Exhibit 71: Herbs Nutriproducts Pvt. Ltd. - Product segments
Exhibit 72: Herbs Nutriproducts Pvt. Ltd. - Key offerings
Exhibit 73: Jyorana International Pvt. Ltd. - Vendor overview
Exhibit 74: Jyorana International Pvt. Ltd. - Business segments
Exhibit 75: Jyorana International Pvt. Ltd. - Key offerings
Exhibit 76: Natures Aid Ltd. - Vendor overview
Exhibit 77: Natures Aid Ltd. - Product segments
Exhibit 78: Natures Aid Ltd. - Key offerings
Exhibit 79: NOW Health Group Inc. - Vendor overview
Exhibit 80: NOW Health Group Inc. - Product segments
Exhibit 81: NOW Health Group Inc. - Organizational developments
Exhibit 82: NOW Health Group Inc. - Key offerings
Exhibit 83: Pharma Nord Aps - Vendor overview
Exhibit 84: Pharma Nord Aps - Business segments
Exhibit 85: Pharma Nord Aps - Key offerings
Exhibit 86: WynnPharm Inc. - Vendor overview
Exhibit 87: WynnPharm Inc. - Product segments
Exhibit 88: WynnPharm Inc. - Key offerings
Exhibit 89: Validation techniques employed for market sizing
Exhibit 90: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Blackmores Ltd.
  • Cargill Inc.
  • Ethical Naturals Inc.
  • GNC Holdings Inc.
  • Natures Aid Ltd.
  • NOW Health Group Inc.
  • MORE
The following companies as the key players in the global glucosamine market: Blackmores Ltd., Cargill Inc., Ethical Naturals Inc., GNC Holdings Inc., Herbs Nutriproducts Pvt. Ltd., Jyorana International Pvt. Ltd., Natures Aid Ltd., NOW Health Group Inc., Pharma Nord Aps, and WynnPharm Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the growing use of nutraceuticals in treating chronic diseases.”

According to the report, one of the major drivers for this market is the increasing use of combination therapy.

Further, the report states that one of the major factors hindering the growth of this market is the limitations on the variation of molecule type.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Blackmores Ltd.
  • Cargill Inc.
  • Ethical Naturals Inc.
  • GNC Holdings Inc.
  • Herbs Nutriproducts Pvt. Ltd.
  • Jyorana International Pvt. Ltd.
  • Natures Aid Ltd.
  • NOW Health Group Inc.
  • Pharma Nord Aps
  • WynnPharm Inc.
Note: Product cover images may vary from those shown
Adroll
adroll